Ducommun B - Search Results

1

What's new on CDC25 phosphatase inhibitors.

Contour-Galcera MO, Sidhu A, Prévost G, Bigg D, Ducommun B. Contour-Galcera MO, et al. Among authors: ducommun b. Pharmacol Ther. 2007 Jul;115(1):1-12. doi: 10.1016/j.pharmthera.2007.03.009. Epub 2007 Apr 21. Pharmacol Ther. 2007. PMID: 17531323 Review.

2

Inhibitors of the CDC25 phosphatases.

Prevost GP, Brezak MC, Goubin F, Mondesert O, Galcera MO, Quaranta M, Alby F, Lavergne O, Ducommun B. Prevost GP, et al. Among authors: ducommun b. Prog Cell Cycle Res. 2003;5:225-34. Prog Cell Cycle Res. 2003. PMID: 14593717 Review.

3

A novel synthetic inhibitor of CDC25 phosphatases: BN82002.

Brezak MC, Quaranta M, Mondésert O, Galcera MO, Lavergne O, Alby F, Cazales M, Baldin V, Thurieau C, Harnett J, Lanco C, Kasprzyk PG, Prevost GP, Ducommun B. Brezak MC, et al. Among authors: ducommun b. Cancer Res. 2004 May 1;64(9):3320-5. doi: 10.1158/0008-5472.can-03-3984. Cancer Res. 2004. PMID: 15126376

4

Synthesis of small molecule CDC25 phosphatases inhibitors.

Contour-Galcéra MO, Lavergne O, Brezak MC, Ducommun B, Prévost G. Contour-Galcéra MO, et al. Among authors: ducommun b. Bioorg Med Chem Lett. 2004 Dec 6;14(23):5809-12. doi: 10.1016/j.bmcl.2004.09.041. Bioorg Med Chem Lett. 2004. PMID: 15501045

5

Inhibition of human tumor cell growth in vivo by an orally bioavailable inhibitor of CDC25 phosphatases.

Brezak MC, Quaranta M, Contour-Galcera MO, Lavergne O, Mondesert O, Auvray P, Kasprzyk PG, Prevost GP, Ducommun B. Brezak MC, et al. Among authors: ducommun b. Mol Cancer Ther. 2005 Sep;4(9):1378-87. doi: 10.1158/1535-7163.MCT-05-0168. Mol Cancer Ther. 2005. PMID: 16170030

6

Synthesis and biological evaluation of novel heterocyclic quinones as inhibitors of the dual specificity protein phosphatase CDC25C.

Lavergne O, Fernandes AC, Bréhu L, Sidhu A, Brézak MC, Prévost G, Ducommun B, Contour-Galcera MO. Lavergne O, et al. Among authors: ducommun b. Bioorg Med Chem Lett. 2006 Jan 1;16(1):171-5. doi: 10.1016/j.bmcl.2005.09.030. Epub 2005 Oct 10. Bioorg Med Chem Lett. 2006. PMID: 16216500

7

IRC-083864, a novel bis quinone inhibitor of CDC25 phosphatases active against human cancer cells.

Brezak MC, Valette A, Quaranta M, Contour-Galcera MO, Jullien D, Lavergne O, Frongia C, Bigg D, Kasprzyk PG, Prevost GP, Ducommun B. Brezak MC, et al. Among authors: ducommun b. Int J Cancer. 2009 Mar 15;124(6):1449-56. doi: 10.1002/ijc.24080. Int J Cancer. 2009. PMID: 19065668 Free article.

8

A fission yeast strain expressing human CDC25A phosphatase: a tool for selectivity studies of pharmacological inhibitors of CDC25.

Mondesert O, Lemaire M, Brezak MC, Galera-Contour MO, Prevost G, Ducommun B, Bugler B. Mondesert O, et al. Among authors: ducommun b. Curr Genet. 2004 May;45(5):283-8. doi: 10.1007/s00294-003-0483-3. Epub 2004 Jan 15. Curr Genet. 2004. PMID: 14727060

9

Genotoxic-activated G2-M checkpoint exit is dependent on CDC25B phosphatase expression.

Bugler B, Quaranta M, Aressy B, Brezak MC, Prevost G, Ducommun B. Bugler B, et al. Among authors: ducommun b. Mol Cancer Ther. 2006 Jun;5(6):1446-51. doi: 10.1158/1535-7163.MCT-06-0099. Mol Cancer Ther. 2006. PMID: 16818502 Free article.

10

Pharmacologic inhibition of CDC25 phosphatases impairs interphase microtubule dynamics and mitotic spindle assembly.

Cazales M, Boutros R, Brezak MC, Chaumeron S, Prevost G, Ducommun B. Cazales M, et al. Among authors: ducommun b. Mol Cancer Ther. 2007 Jan;6(1):318-25. doi: 10.1158/1535-7163.MCT-06-0299. Mol Cancer Ther. 2007. PMID: 17237290 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

149 results

Search Page